S
Syros Pharmaceuticals, Inc.
Q1 2024 earnings expected
Quarter
Jan – Mar
Expected
May 15, 2024(ET)
EPS
This quarter-$0.79
Year ago (Mar '23)-$0.54▼ -47.4%
Revenue Growth Trajectory
Last 6 quarters · 1 analysts
Syros Pharmaceuticals, Inc.
Jan – Mar
May 15, 2024(ET)
Last 6 quarters · 1 analysts